Downregulation of the creatine transporter SLC6A8 by JAK2

Journal of Membrane Biology

Volumn 245, Issue 3, 2012, Pages 157-163

  Shojaiefard, Manzar ^a,b   Hosseinzadeh, Zohreh ^a,c   Bhavsar, Shefalee K ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b FASA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

Author keywords

AG490; Brefeldin; Creatine uptake; Energy depletion; Erythropoietin; Leptin

Indexed keywords

AMINO ACID TRANSPORTER; BREFELDIN A; COMPLEMENTARY RNA; CREATINE; JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN SLC6A8; UNCLASSIFIED DRUG; WATER;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CONTROLLED STUDY; DOWN REGULATION; ENZYME KINETICS; ENZYME REGULATION; FEMALE; NONHUMAN; OOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; VOLTAGE CLAMP; XENOPUS;

ANIMALS; BIOLOGICAL TRANSPORT; BREFELDIN A; CREATINE; DOWN-REGULATION; HUMANS; JANUS KINASE 2; MEMBRANE TRANSPORT PROTEINS; OOCYTES; PROTEIN SYNTHESIS INHIBITORS; TYRPHOSTINS; XENOPUS;

EID: 84863522282     PISSN: 00222631     EISSN: 14321424     Source Type: Journal    
DOI: 10.1007/s00232-012-9424-8     Document Type: Article

References (68)

1. Alcaide P, Rodriguez-Pombo P, Ruiz-Sala P, Ferrer I, Castro P, Ruiz MY, Merinero B, Ugarte M (2010) A new case of creatine transporter deficiency associated with mild clinical phenotype and a novel mutation in the SLC6A8 gene. Dev Med Child Neurol 52:215-217
2. Alcaide P, Merinero B, Ruiz-Sala P, Richard E, Navarrete R, Arias A, Ribes A, Artuch R, Campistol J, Ugarte M, Rodriguez-Pombo P (2011) Defining the pathogenicity of creatine deficiency syndrome. Hum Mutat 32:282-291
3. Anselm IA, Coulter DL, Darras BT (2008) Cardiac manifestations in a child with a novel mutation in creatine transporter gene SLC6A8. Neurology 70:1642-1644 (Pubitemid 351620323)
4. Ardon O, Amat di San FC, Salomons GS, Longo N (2010) Creatine transporter deficiency in two half-brothers. Am J Med Genet A 152A:1979-1983
5. Baskin R, Majumder A, Sayeski PP (2010) The recent medicinal chemistry development of Jak2 tyrosine kinase small molecule inhibitors. Curr Med Chem 17:4551-4558
6. Battini R, Chilosi A, Mei D, Casarano M, Alessandri MG, Leuzzi V, Ferretti G, Tosetti M, Bianchi MC, Cioni G (2007) Mental retardation and verbal dyspraxia in a new patient with de novo creatine transporter (SLC6A8) mutation. Am J Med Genet A 143A:1771-1774 (Pubitemid 47217277)
7. Battini R, Chilosi AM, Casarano M, Moro F, Comparini A, Alessandri MG, Leuzzi V, Tosetti M, Cioni G (2011) Language disorder with mild intellectual disability in a child affected by a novel mutation of SLC6A8 gene. Mol Genet Metab 102: 153-156
8. Bhavsar SK, Hosseinzadeh Z, Merches K, Gu S, Broer S, Lang F (2011) Stimulation of the amino acid transporter SLC6A19 by JAK2. Biochem Biophys Res Commun 414:456-461
9. Bohmer C, Sopjani M, Klaus F, Lindner R, Laufer J, Jeyaraj S, Lang F, Palmada M (2010) The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19. Cell Physiol Biochem 25:723-732
10. Braissant O, Henry H (2008) AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review. J Inherit Metab Dis 31:230-239
11. Braissant O, Beard E, Torrent C, Henry H (2010) Dissociation of AGAT, GAMT and SLC6A8 in CNS: relevance to creatine deficiency syndromes. Neurobiol Dis 37:423-433
12. Braissant O, Henry H, Beard E, Uldry J (2011) Creatine deficiency syndromes and the importance of creatine synthesis in the brain. Amino Acids 40:1315-1324
13. Brault JJ, Abraham KA, Terjung RL (2003) Muscle creatine uptake and creatine transporter expression in response to creatine supplementation and depletion. J Appl Physiol 94:2173-2180 (Pubitemid 36605275)
14. Brooks AJ, Waters MJ (2010) The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol 6:515-525
15. Christie DL (2007) Functional insights into the creatine transporter. Subcell Biochem 46:99-118
16. + exchanger in podocytes through a mechanism that involves Janus kinase and calmodulin. Biochim Biophys Acta 1793:1174-1181
17. Dodd JR, Christie DL (2001) Cysteine 144 in the third transmembrane domain of the creatine transporter is located close to a substrate-binding site. J Biol Chem 276:46983-46988
18. Feng J, Witthuhn BA, Matsuda T, Kohlhuber F, Kerr IM, Ihle JN (1997) Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol Cell Biol 17:2497-2501 (Pubitemid 27175130)
19. + exchange through Janus kinase 2 and calmodulin. J Biol Chem 278:16908-16915 (Pubitemid 36799563)
20. Gatsios P, Terstegen L, Schliess F, Haussinger D, Kerr IM, Heinrich PC, Graeve L (1998) Activation of the Janus kinase/signal transducer and activator of transcription pathway by osmotic shock. J Biol Chem 273:22962-22968 (Pubitemid 28417472)
21. Gehring EM, Zurn A, Klaus F, Laufer J, Sopjani M, Lindner R, Strutz- Seebohm N, Tavare JM, Boehmer C, Palmada M, Lang UE, Seebohm G, Lang F (2009) Regulation of the glutamate transporter EAAT2 by PIKfyve. Cell Physiol Biochem 24:361-368
22. Gong TW, Meyer DJ, Liao J, Hodge CL, Campbell GS, Wang X, Billestrup N, Carter-Su C, Schwartz J (1998) Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors. Endocrinology 139:1863-1871 (Pubitemid 28513847)
23. +-dependent creatine transporter in rabbit brain, muscle, heart, and kidney: cDNA cloning and functional expression. J Biol Chem 268:8418-8421 (Pubitemid 23118616)
24. Hahn KA, Salomons GS, Tackels-Horne D, Wood TC, Taylor HA, Schroer RJ, Lubs HA, Jakobs C, Olson RL, Holden KR, Stevenson RE, Schwartz CE (2002) X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28. Am J Hum Genet 70:1349-1356 (Pubitemid 34450585)
25. Handler JS, Kwon HM (1996) Regulation of the myo-inositol and betaine cotransporters by tonicity. Kidney Int 49:1682-1683 (Pubitemid 26186598)
26. Ho K, Valdez F, Garcia R, Tirado CA (2010) JAK2 translocations in hematological malignancies: review of the literature. J Assoc Genet Technol 36:107-109
27. Hoffmann EK, Pedersen SF (2006) Sensors and signal transduction pathways in vertebrate cell volume regulation. Contrib Nephrol 152:54-104 (Pubitemid 44672103)
28. Hosseinzadeh Z, Bhavsar SK, Shojaiefard M, Saxena A, Merches K, Sopjani M, Alesustan I, Lang F (2011) Stimulation of the glucose carrier SGLT1 by JAK2. Biochem Biophys Res Commun 408:208-213
29. Jensen LR, Chen W, Moser B, Lipkowitz B, Schroeder C, Musante L, Tzschach A, Kalscheuer VM, Meloni I, Raynaud M, van Esch H, Chelly J, de Brouwer AP, Hackett A, van der Haar S, Henn W, Gecz J, Riess O, Bonin M, Reinhardt R, Ropers HH, Kuss AW (2011) Hybridisation-based resequencing of 17 X-linked intellectual disability genes in 135 patients reveals novel mutations in ATRX, SLC6A8 and PQBP1. Eur J Hum Genet 19:717-720
30. Kurdi M, Booz GW (2009) JAK redux: a second look at the regulation and role of JAKs in the heart. Am J Physiol Heart Circ Physiol 297:H1545-H1556
31. Li H, Thali RF, Smolak C, Gong F, Alzamora R, Wallimann T, Scholz R, Pastor-Soler NM, Neumann D, Hallows KR (2010) Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells. Am J Physiol Renal Physiol 299:F167-F177
32. Loike JD, Zalutsky DL, Kaback E, Miranda AF, Silverstein SC (1988) Extracellular creatine regulates creatine transport in rat and human muscle cells. Proc Natl Acad Sci USA 85:807-811 (Pubitemid 18073920)
33. Longo N, Ardon O, Vanzo R, Schwartz E, Pasquali M (2011) Disorders of creatine transport and metabolism. Am J Med Genet C Semin Med Genet 157:72-78
34. Lopez AF, Hercus TR, Ekert P, Littler DR, Guthridge M, Thomas D, Ramshaw HS, Stomski F, Perugini M, D'Andrea R, Grimbaldeston M, Parker MW (2010) Molecular basis of cytokine receptor activation. IUBMB Life 62:509-518
35. Mahfouz RA, Hoteit R, Salem Z, Bazarbachi A, Mugharbel A, Farhat F, Ziyadeh A, Ibrahim A, Taher A (2011) JAK2 V617F gene mutation in the laboratory work-up of myeloproliferative disorders: experience of a major referral center in Lebanon. Genet Test Mol Biomarkers 15:263-265
36. Mak CS, Waldvogel HJ, Dodd JR, Gilbert RT, Lowe MT, Birch NP, Faull RL, Christie DL (2009) Immunohistochemical localization of the creatine transporter in the rat brain. Neuroscience 163: 571-585
37. Mancardi MM, Caruso U, Schiaffino MC, Baglietto MG, Rossi A, Battaglia FM, Salomons GS, Jakobs C, Zara F, Veneselli E, Gaggero R (2007) Severe epilepsy in X-linked creatine transporter defect (CRTR-D). Epilepsia 48:1211-1213 (Pubitemid 46854888)
38. Mellott TJ, Kowall NW, Lopez-Coviella I, Blusztajn JK (2007) Prenatal choline deficiency increases choline transporter expression in the septum and hippocampus during postnatal development and in adulthood in rats. Brain Res 1151:1-11 (Pubitemid 46709862)
39. Mercimek-Mahmutoglu S, Connolly MB, Poskitt KJ, Horvath GA, Lowry N, Salomons GS, Casey B, Sinclair G, Davis C, Jakobs C, Stockler-Ipsiroglu S (2010) Treatment of intractable epilepsy in a female with SLC6A8 deficiency. Mol Genet Metab 101: 409-412
40. Mohamed MR, Alesutan I, Foller M, Sopjani M, Bress A, Baur M, Salama RH, Bakr MS, Mohamed MA, Blin N, Lang F, Pfister M (2010) Functional analysis of a novel I71 N mutation in the GJB2 gene among southern Egyptians causing autosomal recessive hearing loss. Cell Physiol Biochem 26:959-966
41. Morris DL, Rui L (2009) Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 297:E1247-E1259
42. Nash SR, Giros B, Kingsmore SF, Rochelle JM, Suter ST, Gregor P, Seldin MF, Caron MG (1994) Cloning, pharmacological characterization, and genomic localization of the human creatine transporter. Recept Channels 2:165-174 (Pubitemid 24262703)
43. +-creatine cotransporter in failing human myocardium and in experimental heart failure. Circulation 100: 1847-1850 (Pubitemid 29511136)
44. Oh ST, Gotlib J (2010) JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms. Expert Rev Hematol 3:323-337
45. Omerovic E, Bollano E, Lorentzon M, Walser M, Mattsson-Hulten L, Isgaard J (2003) Growth hormone induces myocardial expression of creatine transporter and decreases plasma levels of IL- 1beta in rats during early post-infarct cardiac remodeling. Growth Horm IGF Res 13:239-245 (Pubitemid 37167937)
46. Pardanani A, Vannucchi AM, Passamonti F, Cervantes F, Barbui T, Tefferi A (2011) JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations. Leukemia 25:218-225
47. Pasantes-Morales H, Cruz-Rangel S (2010) Brain volume regulation: osmolytes and aquaporin perspectives. Neuroscience 168: 871-884
48. Puusepp H, Kall K, Salomons GS, Talvik I, Mannamaa M, Rein R, Jakobs C, Ounap K (2009) The screening of SLC6A8 deficiency among Estonian families with X-linked mental retardation. J Inherit Metab Dis. doi:10.1007/s10545-008-1063-y
49. Rexhepaj R, Dermaku-Sopjani M, Gehring EM, Sopjani M, Kempe DS, Foller M, Lang F (2010) Stimulation of electrogenic glucose transport by glycogen synthase kinase 3. Cell Physiol Biochem 26:641-646
50. Rosenberg EH, Martinez MC, Betsalel OT, van Dooren SJ, Fernandez M, Jakobs C, Degrauw TJ, Kleefstra T, Schwartz CE, Salomons GS (2007) Functional characterization of missense variants in the creatine transporter gene (SLC6A8): improved diagnostic application. Hum Mutat 28:890-896 (Pubitemid 47579939)
51. Salomons GS, van Dooren SJ, Verhoeven NM, Marsden D, Schwartz C, Cecil KM, Degrauw TJ, Jakobs C (2003) X-linked creatine transporter defect: an overview. J Inherit Metab Dis 26:309-318 (Pubitemid 36889750)
52. Santos FP, Verstovsek S (2011) JAK2 inhibitors: what's the true therapeutic potential+ Blood Rev 25:53-63
53. Shojaiefard M, Christie DL, Lang F (2005) Stimulation of the creatine transporter SLC6A8 by the protein kinases SGK1 and SGK3. Biochem Biophys Res Commun 334:742-746 (Pubitemid 41033184)
54. Shojaiefard M, Christie DL, Lang F (2006) Stimulation of the creatine transporter SLC6A8 by the protein kinase mTOR. Biochem Biophys Res Commun 341:945-949 (Pubitemid 43221757)
55. Skelton MR, Schaefer TL, Graham DL, Degrauw TJ, Clark JF, Williams MT, Vorhees CV (2011) Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency. PLoS ONE 6:e16187
56. Sora I, Richman J, Santoro G, Wei H, Wang Y, Vanderah T, Horvath R, Nguyen M, Waite S, Roeske WR (1994) The cloning and expression of a human creatine transporter. Biochem Biophys Res Commun 204:419-427 (Pubitemid 24335311)
57. Speer O, Neukomm LJ, Murphy RM, Zanolla E, Schlattner U, Henry H, Snow RJ, Wallimann T (2004) Creatine transporters: a reappraisal. Mol Cell Biochem 256-257:407-424 (Pubitemid 38181262)
58. Spivak JL (2010) Thrombocytosis, polycythemia vera, and JAK2 mutations: the phenotypic mimicry of chronic myeloproliferation. Ann Intern Med 152:300-306
59. Stockler S, Schutz PW, Salomons GS (2007) Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology. Subcell Biochem 46:149-166
60. Strutz-Seebohm N, Shojaiefard M, Christie D, Tavare J, Seebohm G, Lang F (2007) PIKfyve in the SGK1 mediated regulation of the creatine transporter SLC6A8. Cell Physiol Biochem 20:729-734 (Pubitemid 350059717)
61. Takenaka M, Bagnasco SM, Preston AS, Uchida S, Yamauchi A, Kwon HM, Handler JS (1995) The canine betaine gammaamino- n-butyric acid transporter gene: diverse mRNA isoforms are regulated by hypertonicity and are expressed in a tissuespecific manner. Proc Natl Acad Sci USA 92:1072-1076
62. Tefferi A (2010) Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH, and IKZF1. Leukemia 24:1128-1138
63. Tefferi A, Skoda R, Vardiman JW (2009) Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat Rev Clin Oncol 6:627-637
64. Tran TT, Dai W, Sarkar HK (2000) Cyclosporin A inhibits creatine uptake by altering surface expression of the creatine transporter. J Biol Chem 275:35708-35714
65. --dependent taurine transporter that is regulated by hypertonicity. Proc Natl Acad Sci USA 89:8230-8234
66. van de Kamp JM, Mancini GM, Pouwels PJ, Betsalel OT, van Dooren SJ, de Koning I, Steenweg ME, Jakobs C, van der Knaap MS, Salomons GS (2011) Clinical features and X-inactivation in females heterozygous for creatine transporter defect. Clin Genet 79:264-272
67. Wang W, Jobst MA, Bell B, Zhao CR, Shang LH, Jacobs DO (2002) Cr supplementation decreases tyrosine phosphorylation of the CreaT in skeletal muscle during sepsis. Am J Physiol Endocrinol Metab 282:E1046-E1054 (Pubitemid 34654718)
68. Yokota I, Hayashi H, Matsuda J, Saijo T, Naito E, Ito M, Ebina Y, Kuroda Y (1998) Effect of growth hormone on the translocation of GLUT4 and its relation to insulin-like and anti-insulin action. Biochim Biophys Acta 1404:451-456 (Pubitemid 28470546)